The Economic Burden of Anxiety Disorders in the 1990s
The DOI matches its Crossref record.
Abstract
BACKGROUND: We assess the annual economic burden of anxiety disorders in the United States from a societal perspective. METHOD: Using data from the National Comorbidity Study, we applied multivariate regression techniques to calculate the costs associated with anxiety disorders, after adjusting for demographic characteristics and the presence of comorbid psychiatric conditions. Based on additional data, in part from a large managed care organization, we estimated a human capital model of the societal cost of anxiety disorders. RESULTS: We estimated the annual cost of anxiety disorders to be approximately $42.3 billion in 1990 in the United States, or $1542 per sufferer. This comprises $23.0 billion (or 54% of the total cost) in nonpsychiatric medical treatment costs, S13.3 billion (31%) in psychiatric treatment costs, $4.1 billion (10%) in indirect workplace costs, $1.2 billion (3%) in mortality costs, and $0.8 billion (2%) in prescription pharmaceutical costs. Of the $256 in workplace costs per anxious worker, 88% is attributable to lost productivity while at work as opposed to absenteeism. Posttraumatic stress disorder and panic disorder are the anxiety disorders found to have the highest rates of service use. Other than simple phobia, all anxiety disorders analyzed are associated with impairment in workplace performance. CONCLUSION: Anxiety disorders impose a substantial cost on society, much of which may be avoidable with more widespread awareness, recognition, and appropriate early intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Economic costs associated with anxiety disorders are among the highest of all mental disorders studied.[2][3][4][5][6]”
From The Classification of Anxiety and Fear-Related Disorders in the ICD-11: Review: Anxiety and Fear-Related Disorders in ICD-11 (2016) · cites this paper as [3]
Citations
Cited by
Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741
“More than 30 million Americans have a lifetime history of anxiety (15), and anxiety disorders cost an estimated $42 billion dollars per year in the United States alone, counting direct and indirect costs (16).”
BackgroundKessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
“A number of studies, for example, have documented high societal costs of anxiety (58,59), mood (60,61), and substance (62,63) disorder, but these all ignored the role of comorbid ADHD.”
BackgroundSelf-citationThe size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
McLean, C. P., Asnaani, A., Litz, B. T., & Hofmann, S. G. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.03.006 · Cited by 2,519
“In fact, an analysis by Greenberg et al. (1999) showed that more than half of the cost linked to anxiety disorders is attributable to nonpsychiatric medical expenditures.”
BackgroundDoes low self-esteem predict depression and anxiety? A meta-analysis of longitudinal studies.
Sowislo, J. F., & Orth, U. (2013) · Psychological Bulletin · doi:10.1037/a0028931 · Cited by 2,123
The Neurocircuitry of Fear, Stress, and Anxiety Disorders
Shin, L. M., & Liberzon, I. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.83 · Cited by 2,083
“Anxiety disorders are associated with impaired workplace performance and hefty economic costs (Greenberg et al, 1999), as well as an increased risk of cardiovascular morbidity and mortality (Albert et al, 2005; Kawachi et al, 1994; Smoller et al, 2007).”
BackgroundThe global burden of mental disorders: An update from the WHO World Mental Health (WMH) surveys
Kessler, R. C., Aguilar-Gaxiola, S., Alonso, J., Chatterji, S., Lee, S., Ormel, J., Üstün, T. B., & Wang, P. S. (2009) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00001421 · Cited by 1,895
Self-citationPlummer, F., Manea, L., Trepel, D., & McMillan, D. (2016) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.11.005 · Cited by 1,882
Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies
Wittchen, H.-U., & Jacobi, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.012 · Cited by 1,503
“Consistent with numerous earlier studies for specific diagnoses (Bijl and Ravelli, 2000a; Jacobi et al., 2004b; Greenberg et al., 1996, 1999; Kessler and Frank, 1997; Rice and Miller, 1998; Spijker et al., 2004; Wittchen, 2002) and expert-based WHO projections (i.e. Murray and Lopez, 1996; Olesen…”
ResultRebooting psychotherapy research and practice to reduce the burden of mental illness
Kazdin, A. E., & Blase, S. L. (2011) · Perspectives on Psychological Science · doi:10.1177/1745691610393527 · Cited by 1,254
“For anxiety disorders, annual health-care expenditures in the United States are approximately $42 billion (Greenberg et al., 1999).”
BackgroundGoetzel, R. Z., Long, S. R., Ozminkowski, R. J., Hawkins, K., Wang, S., & Lynch, W. (2004) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000121151.40413.bd · Cited by 1,259
“Greenberg et al.(47) focused on posttraumatic stress disorder and anxiety disorder, noting that approximately 10% of the total costs for these were related to workplace costs.”
BackgroundThe Journal of Mental Health Policy and Economics
(2006) · The Journal of Mental Health Policy and Economics · doi:10.1002/(issn)1099-176x · Cited by 1,243
Child sexual abuse and subsequent psychopathology: results from the National Comorbidity Survey
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.5.753 · Cited by 1,198
Self-citationCost of disorders of the brain in Europe
Andlin‐Sobocki, P., Jönsson, B., Wittchen, H., & Olesen, J. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01202.x · Cited by 1,139
“1990; Rice & Miller 1995) Anxiety disorders 41 44–48 (DuPont et al. 1999; Greenberg et al. 1999; Rice & Miller 1998) Psychotic disorders 35 34 (Rice 1999) Addiction 57 160–389 (Holland & Mushinski 1992; Rice 1995; Rice et al.”
BackgroundTargeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
Ressler, K. J., & Mayberg, H. S. (2007) · Nature Neuroscience · doi:10.1038/nn1944 · Cited by 1,007
A meta-analytic review of prolonged exposure for posttraumatic stress disorder
Powers, M. B., Halpern, J. M., Ferenschak, M. P., Gillihan, S. J., & Foa, E. B. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.04.007 · Cited by 1,005
Preliminary evidence for an emotion dysregulation model of generalized anxiety disorder
Mennin, D. S., Heimberg, R. G., Turk, C. L., & Fresco, D. M. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.08.008 · Cited by 919
“D.S. Mennin et al. / Behaviour Research and Therapy ] (]]]]) ]]]–]]]2 1991), increased health care costs and decreased productivityy (Greenberg et al., 1999).”
BackgroundWhat Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 862
Cost-of-illness studies: concepts, scopes, and methods
Jo, C. (2014) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2014.20.4.327 · Cited by 800
A systematic review of reviews on the prevalence of anxiety disorders in adult populations
Remes, O., Brayne, C., van der Linde, R., & Lafortune, L. (2016) · Brain and Behavior · doi:10.1002/brb3.497 · Cited by 802
“The prevalence of anxiety disorders in the United States is estimated to be 18% (Kessler et al. 2005), and their annual cost is reported to be $42.3 billion (Greenberg et al. 1999).”
BackgroundInfluentialSchnurr, P. P., Friedman, M. J., Engel, C. C., Foa, E. B., Shea, M. T., Chow, B. K., Resick, P. A., Thurston, V., Orsillo, S. M., Haug, R., et al. (2007) · JAMA · doi:10.1001/jama.297.8.820 · Cited by 813
“The disorder is associated with psychiatric and physical comorbidity, reduced quality of life,(2-4) and substantial economic costs to society.(5) Lifetime prevalence in US adults is higher in women (9.”
BackgroundExercise for the treatment of depression and anxiety
Carek, P. J., Laibstain, S. E., & Carek, S. M. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.41.1.c · Cited by 797
“Depression and anxiety disorders are some of the most prevalent neurological disorders in the United States, with as many as 18% of adults demonstrating symptoms.”
BackgroundInfluentialThe prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
Halbreich, U., Borenstein, J., Pearlstein, T., & Kahn, L. S. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00098-2 · Cited by 740
“In one study of individuals with anxiety disorders, the majority (88%) of workplace costs were due to decreased productivity (Greenberg et al., 1999).”
BackgroundGeneralized anxiety disorder: prevalence, burden, and cost to society
Wittchen, H.-U. (2002) · Depression and Anxiety · doi:10.1002/da.10065 · Cited by 733
“GAD reduces work productivity and increases the utilization of health care services [Greenberg et al., 1999; Souêtre et al., 1994], and comorbidity, particularly with depression, further increases levels of impairment and cost [Bakish, 1999; Greenberg et al., 1999; Souêtre et al., 1994; Weiller…”
InfluentialToussaint, A., Hüsing, P., Gumz, A., Wingenfeld, K., Härter, M., Schramm, E., & Löwe, B. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.032 · Cited by 641
Roemer, L., & Orsillo, S. M. (2002) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.9.1.54 · Cited by 621
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
“Anxiety disorders are associated with a substantial economic burden, both for the health system and (especially) for the wider society in terms of productivity losses (I) (Souetre et al., 1994; Salvador-Carulla et al., 1995; Rice and Miller, 1998; Greenberg et al., 1999; Andlin-Sobocki & Wittchen, 2005), but there hav…”
BackgroundSelf-citationBrumariu, L. E., & Kerns, K. A. (2010) · Development and Psychopathology · doi:10.1017/s0954579409990344 · Cited by 606
“Given the cognitive, emotional, and behavioral impairments associated with anxiety and depression, as well as the high costs associated with their treatment (Greenberg et al., 1999), it is important to develop and test theories addressing their etiology.”
BackgroundEffects of exercise and physical activity on anxiety
Anderson, E., & Shivakumar, G. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00027 · Cited by 602
“The economic burden of anxiety disorders in the US was estimated to be $42.3 billion in the 1990s (Greenberg et al., 1999).”
BackgroundInfluentialFawcett, E. J., Fairbrother, N., Cox, M. L., White, I. R., & Fawcett, J. M. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.18r12527 · Cited by 609
“Quality ratings were then reported categorically for each study, corresponding to low (0-3), moderate (4-6), or high (7-10) quality scores.”
BackgroundBair, M. J., Wu, J., Damush, T. M., Sutherland, J. M., & Kroenke, K. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318185c510 · Cited by 572
“Anxiety disorders afflict 30 million Americans in their lifetime (16), and cost the US an estimated $42 billion per year in direct and indirect costs (17).”
BackgroundThe developmental origins of anxiety
Gross, C., & Hen, R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1429 · Cited by 566
Attention training for generalized social anxiety disorder
Schmidt, N. B., Richey, J. A., Buckner, J. D., & Timpano, K. R. (2009) · Journal of Abnormal Psychology · doi:10.1037/a0013643 · Cited by 546
Ellard, K. K., Fairholme, C. P., Boisseau, C. L., Farchione, T. J., & Barlow, D. H. (2010) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2009.06.002 · Cited by 523
“Anxiety disorders alone represent a cost to this country of over $42 billion annually (Greenberg et al., 1999).”
Kroenke, K., Wu, J., Yu, Z., Bair, M. J., Kean, J., Stump, T., & Monahan, P. O. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000322 · Cited by 504
“Depression and anxiety also result in substantial disability, representing the second and fifth leading causes of years lived with disability in the United States (7) and accounting for enormous losses in work productivity as well as high direct and indirect health care costs (8,9).”
BackgroundFurmark, T., Tillfors, M., Marteinsdottir, I., Fischer, H., Pissiota, A., Långström, B., & Fredrikson, M. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.5.425 · Cited by 530
“C OMMUNITY SURVEYS indicate that at least 20% of the US population have anxiety disorders(1) and that the annual societal cost of these disorders exceeds $63 billion in 1998 dollars.(2) This underscores the importance of developing efficacious antianxiety treatments, which could be facilitated by a greater understandi…”
BackgroundPrevention and Early Intervention of Anxiety Disorders in Inhibited Preschool Children.
Rapee, R. M., Kennedy, S., Ingram, M., Edwards, S., & Sweeney, L. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.3.488 · Cited by 515
Fourteen-Year Follow-up of Speech/Language-Impaired and Control Children: Psychiatric Outcome
BEITCHMAN, J. H., WILSON, B., JOHNSON, C. J., ATKINSON, L., YOUNG, A., ADLAF, E., ESCOBAR, M., & DOUGLAS, L. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200101000-00019 · Cited by 515
“Anxiety disorders have an impact on the quality of life of affected adults (Wittchen and Beloch, 1996) and represent substantial economic and health care costs (Greenberg et al., 1999).”
BackgroundEpidemiology of Anxiety Disorders
Kessler, R. C., Ruscio, A. M., Shear, K., & Wittchen, H.-U. (2009) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2009_9 · Cited by 496
“For example, Greenberg et al. (1999) estimated that the annual total societal costs of active anxiety disorders in the US over the decade of the 1990s exceeded $42 billion.”
BackgroundSelf-citationTherapeutic applications of compounds in the Magnolia family
Lee, Y.-J., Lee, Y. M., Lee, C.-K., Jung, J. K., Han, S. B., & Hong, J. T. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.010 · Cited by 481
Lifetime Economic Burden of Intimate Partner Violence Among U.S. Adults
Peterson, C., Kearns, M. C., McIntosh, W. L., Estefan, L. F., Nicolaidis, C., McCollister, K. E., Gordon, A., & Florence, C. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.049 · Cited by 471
Computer‐Aided Psychotherapy for Anxiety Disorders: A Meta‐Analytic Review
Cuijpers, P., Marks, I. M., van Straten, A., Cavanagh, K., Gega, L., & Andersson, G. (2009) · Cognitive Behaviour Therapy · doi:10.1080/16506070802694776 · Cited by 429
“The disorders often cause marked impairment in the quality of life of patients and their family (Angermeyer, Kilian, Wilms, & Wittmund, 2006; Mendlowicz & Stein, 2000; Wittmund, Wilms, Mory, & Angermeyer, 2002) and incur major costs (DuPont et al., 1996; Greenberg et al., 1999).”
BackgroundThe economic and social burden of compulsive hoarding
Tolin, D. F., Frost, R. O., Steketee, G., Gray, K. D., & Fitch, K. E. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.08.008 · Cited by 445
“The present data do not permit estimation of the dollar amount of the economic burden of hoarding, as has been reported for other disorders (Greenberg et al., 2003; Greenberg et al., 1999; Wu et al., 2005).”
Human and economic burden of generalized anxiety disorder
Hoffman, D. L., Dukes, E. M., & Wittchen, H.-U. (2008) · Depression and Anxiety · doi:10.1002/da.20257 · Cited by 438
“, gynecologists and cardiologists), and work cutback days [Greenberg et al., 1999].”
BackgroundMethodInfluentialThe Age of Onset of Anxiety Disorders: A Meta-analysis
Lijster, J. M. D., Dierckx, B., Utens, E. M. W. J., Verhulst, F. C., Zieldorff, C., Dieleman, G. C., & Legerstee, J. S. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716640757 · Cited by 426
“Numerous community surveys have shown that anxiety disorders are the most common mental disorders worldwide.1 Anxiety disorders are debilitating and often cause impairment in social and occupational functioning.2,3 Anxiety disorders cause more disability than all other mental health disorders.4 Economic losses arising…”
BackgroundAnxiety disorders and their clinical correlates in multiple sclerosis patients
Korostil, M., & Feinstein, A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071161 · Cited by 424
Tyrer, P., & Baldwin, D. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69865-6 · Cited by 404
Rutter, L. A., & Brown, T. A. (2017) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-016-9571-9 · Cited by 402
“GAD has been linked to indirect costs at the workplace through lost productivity (Greenberg et al. 1999; Hoffman et al. 2006), and it may be a risk factor for the development of comorbid conditions (Roy-Bryne and Katon 1997) including other anxiety disorders (Grant et al. 2009), and alcohol-related…”
Roemer, L., Lee, J. K., Salters-Pedneault, K., Erisman, S. M., Orsillo, S. M., & Mennin, D. S. (2009) · Behavior Therapy · doi:10.1016/j.beth.2008.04.001 · Cited by 392
“, Brown, Campbell, Lehman, Grisham, & Mancill, 2001), significant functional impairment (Kessler, Walters, & Wittchen, 2004), and significant health care costs/utilization (Greenberg et al., 1999).”
Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults
Olthuis, J. V., Watt, M. C., Bailey, K., Hayden, J. A., & Stewart, S. H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011565.pub2 · Cited by 390
Social phobia: overview of community surveys
Furmark, T. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.1r103.x · Cited by 386
Sex differences in anxiety and emotional behavior
Donner, N. C., & Lowry, C. A. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1271-7 · Cited by 379
“In Western civilizations, the lifetime prevalence for anxiety disorders amounts to approximately 18 % of the population [198], the average onset age for anxiety disorders is 11 years of age [269], and while the overall costs of anxiety disorders in the USA were an estimated $42 billion/year during the 1990s [141], men…”
BackgroundPower, M. C., Kioumourtzoglou, M.-A., Hart, J. E., Okereke, O. I., Laden, F., & Weisskopf, M. G. (2015) · BMJ · doi:10.1136/bmj.h1111 · Cited by 377
Disruption of Reconsolidation Erases a Fear Memory Trace in the Human Amygdala
Agren, T., Engman, J., Frick, A., Björkstrand, J., Larsson, E.-M., Furmark, T., & Fredrikson, M. (2012) · Science · doi:10.1126/science.1223006 · Cited by 376
Asmundson, G. J. G., Fetzner, M. G., DeBoer, L. B., Powers, M. B., Otto, M. W., & Smits, J. A. J. (2013) · Depression and Anxiety · doi:10.1002/da.22043 · Cited by 361
“, increased health care costs and utilization).[10, 11] Those affected are often faced with numerous barriers to treatment (e.”
BackgroundImplementation of the CALM intervention for anxiety disorders: a qualitative study
Curran, G. M., Sullivan, G., Mendel, P., Craske, M. G., Sherbourne, C. D., Stein, M. B., McDaniel, A., & Roy-Byrne, P. (2012) · Implementation Science · doi:10.1186/1748-5908-7-14 · Cited by 348
“Individuals with anxiety disorders suffer significant impairment and reduced quality of life [3-5], and they are costly to healthcare systems and economies in general due to high use of healthcare and reduced productivity [6-8].”
BackgroundBjelland, I., Tell, G. S., Vollset, S. E., Refsum, H., & Ueland, P. M. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.618 · Cited by 345
“Both anxiety and depression are common symptoms or disorders with a major impact on public health.(9,10) Although a possible role of nutritional factors in the pathogenesis of neuropsychiatric disorders has long been debated,(11,12) clinical studies have shown an inverse relationship between folate status and depressi…”
Backgroundvan Dis, E. A. M., van Veen, S. C., Hagenaars, M. A., Batelaan, N. M., Bockting, C. L. H., van den Heuvel, R. M., Cuijpers, P., & Engelhard, I. M. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3986 · Cited by 335
Gaps in accessing treatment for anxiety and depression: challenges for the delivery of care
Collins, K. A., Westra, H. A., Dozois, D. J. A., & Burns, D. D. (2004) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.06.001 · Cited by 322
“, 1993) and associated with a significant burden personally, socially, and economically (Greenberg et al., 1999; Katzelnick & Greist, 2001).”
BackgroundInfluentialBallenger, J. C., Davidson, J. R., Lecrubier, Y., Nutt, D., Foa, E. B., Kessler, R. C., McFARLANE, A. C., & Shalev, A. Y. (2000) · PubMed · Cited by 375
Self-citationRoy-Byrne, P. P., Craske, M. G., Stein, M. B., Sullivan, G., Bystritsky, A., Katon, W., Golinelli, D., & Sherbourne, C. D. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.290 · Cited by 314
EARLY INTERVENTIONS FOR PTSD: A REVIEW: Review: Early Intervention
Kearns, M. C., Ressler, K. J., Zatzick, D., & Rothbaum, B. O. (2012) · Depression and Anxiety · doi:10.1002/da.21997 · Cited by 310
The epidemiology of anxiety disorders: prevalence and societal costs.
Lépine, J. (2002) · PubMed · Cited by 396
Lowry-Webster, H. M., Barrett, P. M., & Dadds, M. R. (2001) · Behaviour Change · doi:10.1375/bech.18.1.36 · Cited by 307
Psychological therapies for generalised anxiety disorder
Hunot, V., Churchill, R., Teixeira, V., & Silva de Lima, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001848.pub4 · Cited by 315
Sledjeski, E. M., Speisman, B., & Dierker, L. C. (2008) · Journal of Behavioral Medicine · doi:10.1007/s10865-008-9158-3 · Cited by 300
“3 billion in mental and physical health services, with PTSD ranking as the highest in terms of per person health care expenditures (Greenberg et al. 1999).”
BackgroundLamb, C. E., Ratner, P. H., Johnson, C. E., Ambegaonkar, A. J., Joshi, A. V., Day, D., Sampson, N., & Eng, B. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x112552 · Cited by 288
Grubaugh, A. L., Zinzow, H. M., Paul, L., Egede, L. E., & Frueh, B. C. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.04.003 · Cited by 287
“Finally, data suggest that PTSD may be one of the costliest mental health disorders, with estimated annual productivity losses in excess of $3 billion dollars (Brunello et al., 2001; Greenberg et al., 1999; Kessler, 2000).”
BackgroundAnxiety symptomatology: the association with distress tolerance and anxiety sensitivity
Keough, M. E., Riccardi, C. J., Timpano, K. R., Mitchell, M. A., & Schmidt, N. B. (2010) · Behavior Therapy · doi:10.1016/j.beth.2010.04.002 · Cited by 284
“Anxiety disorders represent the most prevalent form of psychopathology in the United States, and result in substantial disability and economic burden (Greenberg et al., 1999; Kessler et al., 2005).”
BackgroundDoes "subthreshold" posttraumatic stress disorder have any clinical relevance?
Zlotnick, C., Franklin, C. L., & Zimmerman, M. (2002) · Comprehensive Psychiatry · doi:10.1053/comp.2002.35900 · Cited by 283
Epidemiology of anxiety disorders: from surveys to nosology and back.
Stein, D. J., Scott, K. M., de Jonge, P., & Kessler, R. C. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/dstein · Cited by 283
Yalcin, B., Willis-Owen, S. A. G., Fullerton, J., Meesaq, A., Deacon, R. M., Rawlins, J. N. P., Copley, R. R., Morris, A. P., Flint, J., & Mott, R. (2004) · Nature Genetics · doi:10.1038/ng1450 · Cited by 279
“Development and Psychopathology 24 (2012), 1179–1193 # Cambridge University Press 2012 doi:10.1017/S0954579412000636 1179 1998 dollars; Greenberg et al., 1999).”
BackgroundInfluentialLebowitz, E. R., Marin, C., Martino, A., Shimshoni, Y., & Silverman, W. K. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.02.014 · Cited by 268
“Journal of t Volume - / hildhood anxiety disorders are common, chronic, and impairing, and confer major short-term and long-term risks to physical and mental health when not treated successfully.(1,2) Efficacious treatments include cognitive behavioral therapy (CBT) and medications, but are insufficient in up to half…”
Prevalence of posttraumatic stress disorder in Veterans Affairs primary care clinics
Magruder, K. M., Frueh, B. C., Knapp, R. G., Davis, L., Hamner, M. B., Martin, R. H., Gold, P. B., & Arana, G. W. (2005) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2004.11.001 · Cited by 268
“health care delivery system in general [26–28].”
Cognitive-Behavioral Therapy for Anxiety Disorders in Youth
Seligman, L. D., & Ollendick, T. H. (2011) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2011.01.003 · Cited by 263
“high prevalence of anxiety disorders coupled with the negative effects on functioning results in a significant economic burden on society.(7)”
Lost productivity among full‐time workers with mental disorders
Lim, D., Sanderson, K., & Andrews, G. (2000) · The Journal of Mental Health Policy and Economics · doi:10.1002/mhp.93 · Cited by 266
Schmidt, N. B., Eggleston, A. M., Woolaway-Bickel, K., Fitzpatrick, K. K., Vasey, M. W., & Richey, J. A. (2007) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2006.06.002 · Cited by 261
Impact of Generalized Social Anxiety Disorder in Managed Care
Katzelnick, D. J., Kobak, K. A., DeLeire, T., Henk, H. J., Greist, J. H., Davidson, J. R. T., Schneier, F. R., Stein, M. B., & Helstad, C. P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1999 · Cited by 262
“According to results from the National Comorbidity Survey (5), the 12-month prevalence rate of social anxiety disorder, which included both the generalized and nongeneralized subtypes, was 7.9%, with a lifetime prevalence of 13.3%.”
ResultInfluentialSelf-citationFeltner, D. E., Crockatt, J. G., Dubovsky, S. J., Cohn, C. K., Shrivastava, R. K., Targum, S. D., Liu-Dumaw, M., Carter, C. M., & Pande, A. C. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084032.22282.ff · Cited by 260
Introduction to the special section on stepped care models in psychotherapy.
Haaga, D. A. F. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.68.4.547 · Cited by 259
Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis
Konnopka, A., & König, H. (2020) · PharmacoEconomics · doi:10.1007/s40273-019-00849-7 · Cited by 259
Anxiety and alcohol use disorders: comorbidity and treatment considerations
Smith, J. (2012) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v34.4.06 · Cited by 255
“Both types of disorder are associated with substantial societal costs that have been estimated in monetary terms at $184.6 billion per year for AUDs (Harwood 2000) and between $42 and $47 billion for anxiety disorders (DuPont et al. 1996; Greenberg et al. 1999).”
InfluentialNeural circuits in anxiety and stress disorders: a focused review
Liberzon, I., Duval, E., & Javanbakht, A. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s48528 · Cited by 253
Comorbidity of personality disorders in anxiety disorders: A meta-analysis of 30 years of research
Friborg, O., Martinussen, M., Kaiser, S., Øvergård, K. T., & Rosenvinge, J. H. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.004 · Cited by 250
“services (Greenberg et al., 1999).”
Lanius, R. A., Frewen, P. A., Tursich, M., Jetly, R., & McKinnon, M. C. (2015) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v6.27313 · Cited by 246
“…Joffe, & MacQueen, 2007; Meusel, Hall, Fougere, McKinnon, & MacQueen, 2013) implicated in the CEN (Aupperle et al., 2012; Dunkin et al., 2000; Greenberg et al., 1999; Jaeger & Vieta, 2007; Johnsen & Asbjornsen, 2008; Kessler, 2000; Moradi et al., 2012; Olatunji, Cisler, & Tolin, 2007;…”
MethodWipfli, B., Landers, D., Nagoshi, C., & Ringenbach, S. (2011) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2009.01049.x · Cited by 242
“Serotonin levels were derived using BioSource serotonin ELISA kits (BioSource Europe S.A., Nivelles, Belgium; intra-assay variation5 4.7%; interassay variation5 6.0%; linearity5 100%; recovery5 97%).”
BackgroundInfluentialTemperament and Anxiety Disorders
Pérez-Edgar, K., & Fox, N. A. (2005) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.05.008 · Cited by 239
“Together, these disorders affect over 20% of the adult population at one point in life and can exact an annual estimated cost of $44 billion in the United States alone [9].”
BackgroundPrevalence, detection and correlates of PTSD in the primary care setting : a systematic review
Greene, T., Neria, Y., & Gross, R. (2016) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-016-9449-8 · Cited by 238
Mykletun, A. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.8.1412 · Cited by 237
The Role of Glutamate in Anxiety and Related Disorders
Cortese, B. M., & Phan, K. L. (2005) · CNS Spectrums · doi:10.1017/s1092852900010427 · Cited by 232
Economic costs of minor depression: a population-based study
Cuijpers, P., Smit, F., Oostenbrink, J., De Graaf, R., Ten Have, M., & Beekman, A. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00851.x · Cited by 226
“First, the medical costs that were considered in this study were limited to those related to mental health services and psychopharmaca, whereas it is well known that mental disorders also generate medical costs outside the sector of mental health services (34).”
BackgroundAcceptance and Mindfulness-Based Approaches to Anxiety
(2005) · Series in Anxiety and Related Disorders · doi:10.1007/b136521 · Cited by 226
“…class of mental health problems in the United States (Narrow, Rae, Robins, & Regier, 2002) and are associated with significant disruptions in functioning (Leon, Portera, & Weissman, 1995) and substantial health care costs (for both medical and psychological treatment, Greenberg et al., 1999).”
BackgroundGunter, R. W., & Whittal, M. L. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.11.001 · Cited by 224
“For example, Greenberg et al. (1999) estimated the annual cost of anxiety disorders in the United States to be approximately $42.3 billion.”
BackgroundInfluentialLifetime Economic Burden of Rape Among U.S. Adults
Peterson, C., DeGue, S., Florence, C., & Lokey, C. N. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.11.014 · Cited by 224
Schmidt, N. B., Capron, D. W., Raines, A. M., & Allan, N. P. (2014) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0036651 · Cited by 221
“Anxiety disorders represent a highly prevalent form of psychopathology often resulting in substantial disability and economic burden (Greenberg et al., 1999; Kessler, Chiu, Demler, & Walters, 2005).”
BackgroundMetabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs
Palucha, A., & Pilc, A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.04.007 · Cited by 220
Bastani, F., Hidarnia, A., Kazemnejad, A., Vafaei, M., & Kashanian, M. (2005) · Journal of Midwifery & Women's Health · doi:10.1016/j.jmwh.2004.11.008 · Cited by 221
Kroenke, K., Outcalt, S., Krebs, E., Bair, M. J., Wu, J., Chumbler, N., & Yu, Z. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.03.020 · Cited by 212
“66 SF-36 general health [0–100] 58.”
BackgroundInfluentialComer, J. S., Blanco, C., Hasin, D. S., Liu, S.-M., Grant, B. F., Turner, J. B., & Olfson, M. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05094blu · Cited by 214
Alim, T. N., Graves, R. E., Mellman, T. A., Aigbogun, N. U., Gray, E., Lawson, W. B., & Charney, D. S. (2006) · PubMed · Cited by 214
Metadata
- Authors
- Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J.
- Affiliations
- Analysis Group (United States) (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-07-15
- Volume
- 60
- Issue
- 7
- Pages
- 427-435
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2020344785
- Cited by
- 1,242
- References
- 0
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 18 · 2023: 19 · 2022: 25 · 2021: 38 · 2020: 39 · 2019: 47 · 2018: 52 · 2017: 48 · 2016: 73 · 2015: 74 · 2014: 72 · 2013: 82 · 2012: 81
- FWCI
- 46.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- anxiety disorders, economic burden, social costs, health care costs, workplace productivity loss, absenteeism, mortality costs, post-traumatic stress disorder, panic disorder, specific phobia, comorbidities, human capital model
- MeSH terms
- Adolescent, Adult, Anxiety Disorders, Mental Disorders, Cost Allocation, Direct Service Costs, Educational Status, Employment, Family Characteristics, Female, Humans, Male, Managed Care Programs, Middle Aged, Risk Factors, United States, Comorbidity, Drug Costs, Health Care Costs, Workplace, Cost of Illness, Marital Status, Models, Economic, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.